23 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 23 of 23 clinical reviews.
Does ipamorelin increase or suppress appetite? A physician-reviewed breakdown of the mechanisms, clinical data, and practical dosing considerations for ipamorelin acetate and its effects on hunger and food cravings.
A physician-reviewed guide to using ipamorelin acetate in patients with autoimmune conditions: immune modulation mechanisms, safety evidence, contraindications, monitoring protocols, and clinical decision-making frameworks.
A physician-reviewed guide to how ipamorelin acetate affects bone mineral density, IGF-1 signaling, osteoblast activity, and fracture risk, with primary-literature citations and clinical dosing context.
A physician-level review of ipamorelin acetate and cancer risk, covering IGF-1 biology, preclinical data, clinical evidence gaps, and how to screen patients before prescribing.
A physician-reviewed, evidence-based look at how ipamorelin acetate affects the heart and vasculature over months to years, covering GH-axis mechanisms, lipid and endothelial effects, cardiac remodeling data, and clinical monitoring protocols.
A clinician-level review of ipamorelin acetate and its effects on cognitive function, covering GH/IGF-1 pathways, neuroprotection research, dosing protocols, and what patients using GH secretagogues can realistically expect.
A physician-level review of ipamorelin acetate's clinical evidence, graded using the GRADE framework. Covers selectivity data, human trials, off-label status, and what the evidence actually supports.
A physician-reviewed, citation-dense guide to how ipamorelin acetate affects hair growth and skin quality, covering IGF-1 signaling, collagen synthesis, clinical data, dosing, and what to realistically expect.
A detailed, physician-reviewed look at how ipamorelin acetate affects liver function, including ALT/AST changes, IGF-1 signaling through hepatocytes, relevant clinical data, and monitoring protocols for patients on GH secretagogue therapy.
A physician-reviewed deep dive into how ipamorelin acetate affects mood, cognition, sleep quality, and mental wellbeing, with primary-literature citations and clinical context.
How ipamorelin acetate stimulates GH secretion, accelerates lipolysis, and shifts energy expenditure, with primary-literature citations, dosing guidance, and an updated clinical framework.
A source-checked review of ipamorelin microdosing claims, human and animal evidence, FDA compounding findings, and why no validated subcutaneous wellness protocol exists.
A physician-reviewed, evidence-based guide to using ipamorelin acetate for muscle preservation, covering mechanisms, dosing protocols, combination strategies, and primary-literature citations.
MD/PharmD-level guide to diagnosing and correcting ipamorelin plateaus: dosing schedules, receptor desensitization, lifestyle confounders, and when to switch strategies.
A physician-reviewed guide covering ipamorelin acetate use after bariatric surgery, including GH secretagogue physiology, dosing considerations, risks, and the latest clinical evidence.
A physician-reviewed guide covering the ipamorelin acetate pre-surgery hold window, including how long to stop dosing before anesthesia, why GH secretagogues require perioperative planning, and how to restart safely after procedures.
A physician-reviewed guide to what happens when you stop ipamorelin, including GH axis rebound, symptom timelines, withdrawal data, and clinical restart protocols from the HealthRX medical team.
A physician-level review of ipamorelin acetate and kidney health, covering GH/IGF-1 renal physiology, preclinical protection signals, risk factors for GH-axis hyperfiltration, dosing considerations, and what to monitor before and during use.
A physician-reviewed guide to ipamorelin acetate dosing, cycling strategy, and physiological rationale across all four seasons, with primary-literature citations throughout.
A clinician-level review of how ipamorelin acetate affects sexual function, libido, and related hormonal axes, with primary-literature citations, real doses, and a decision framework for prescribers.
A deep clinical review of how ipamorelin acetate alters sleep architecture, slow-wave sleep, and GH pulse timing. Includes trial data, dosing guidance, and physician-reviewed analysis.
A physician-reviewed, week-by-week breakdown of what happens during the first four weeks on ipamorelin acetate, covering sleep, body composition, GH pulse data, and dosing protocols.
A physician-reviewed guide to safely restarting ipamorelin acetate after acute illness, covering timing, dose titration, lab monitoring, and contraindications based on primary endocrinology literature.